86 Kodiak Sciences Inc. Consolidated Balance Sheets (in thousands, except share and per share amounts) December 31, 2023 December 31, 2022 Assets Current assets: Cash and cash equivalents $ 285,507 $ 190,433 Marketable securities — 288,500 Prepaid expenses and other current assets 3,802 7,072 Total current assets 289,309 486,005 Restricted cash 6,324 6,324 Property and equipment, net 120,482 56,384 Operating lease right-of-use asset 54,541 59,369 Other assets 8,716 58,546 Total assets $ 479,372 $ 666,628 Liabilities and stockholders’ equity Current liabilities: Accounts payabl a e $ 13,608 $ 9,130 Accrue r d and other current liabilities 18,351 33,440 Operating lease liabi a lity 9,770 9,926 Total current liabi a lities 41,729 52,496 Operating lease liabi a lity, net of current portion 71,862 77,807 Liability related to sale of future royalties 100,000 99,996 Other liabi a lities — 162 Total liabi a lities 213,591 230,461 Commitments and contingencies (Note 8) Stockholders’ equity: Prefer f red stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively — — Common stock, $0.0001 par value, 490,000,000 shares authorized at December 31, 2023 and December 31, 2022; 52,508,602 and 52,333,850 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 5 5 Additional paid-in capital 1,418,307 1,329,509 Accumulated other comprehensive income (loss) — (1,307) Accumulated deficit (1,152,531) (892,040) Total stockholders’ equity 265,781 436,167 Total liabi a lities and stockholders’ equity $ 479,372 $ 666,628 The accompanying notes are an integral part of these consolidated financial statements.